The role of the NFAT signaling pathway in retinal neovascularization.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3809948)

Published in Invest Ophthalmol Vis Sci on October 25, 2013

Authors

Colin A Bretz1, Sara Savage, Megan Capozzi, John S Penn

Author Affiliations

1: Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.

Articles cited by this

The biology of VEGF and its receptors. Nat Med (2003) 32.13

Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76

Angiogenesis in health and disease. Nat Med (2003) 14.02

Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol (1997) 11.57

Angiogenesis. J Biol Chem (1992) 11.29

Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature (1997) 9.99

Calcium oscillations increase the efficiency and specificity of gene expression. Nature (1998) 9.19

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature (1992) 8.15

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature (1991) 6.30

Blood vessel formation: what is its molecular basis? Cell (1996) 5.54

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98

Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell (2000) 3.44

The vascular endothelial growth factor family of polypeptides. J Cell Biochem (1991) 2.89

Childhood blindness. J AAPOS (1999) 2.75

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol (2002) 2.30

The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology (1996) 2.29

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med (2001) 2.22

NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer (2009) 2.18

Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res (1994) 1.88

NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol (2002) 1.68

Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol Cell Biol (1999) 1.63

NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem (2002) 1.46

Evolutionary relationships among Rel domains indicate functional diversification by recombination. Proc Natl Acad Sci U S A (2001) 1.45

Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol (1989) 1.38

Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc Natl Acad Sci U S A (2004) 1.37

Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. Circ Res (2011) 1.28

The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost (2009) 1.18

HIF-1alpha is up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol (2008) 1.13

The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2001) 1.13

Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc Natl Acad Sci U S A (1992) 1.11

The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci (2009) 1.07

Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology (1999) 1.06

P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways. J Neurochem (2010) 1.03

Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal (2004) 1.02

The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol (2009) 1.01

NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis. Blood (2011) 1.01

Role of cytosolic phospholipase A(2) in retinal neovascularization. Invest Ophthalmol Vis Sci (2009) 1.00

Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis. Cancer Res (2012) 0.97

Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. Invest Ophthalmol Vis Sci (1997) 0.95

Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. Ophthalmology (2007) 0.93

Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell Signal (2005) 0.92

Signaling pathways mediating VEGF165-induced calcium transients and membrane depolarization in human endothelial cells. FASEB J (2006) 0.91

Inhibition of the calcineurin-NFAT interaction by small organic molecules reflects binding at an allosteric site. J Biol Chem (2005) 0.91

Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer. Chin J Cancer (2011) 0.89

Estrogen controls embryonic stem cell proliferation via store-operated calcium entry and the nuclear factor of activated T-cells (NFAT). J Cell Physiol (2012) 0.86

The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells. J Immunol (1995) 0.82

Calcium regulates caveolin-1 expression at the transcriptional level. Biochem Biophys Res Commun (2012) 0.79

Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation. Pharmacogenomics (2005) 0.78

The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization. Curr Eye Res (2010) 0.78

[Expression and significance of COX-2 and its transcription factors NFAT3 and c-Jun in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi (2010) 0.78

Articles by these authors

Mechanisms and management of retinopathy of prematurity. N Engl J Med (2012) 3.52

Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol (2004) 1.39

Animal models of oxygen-induced retinopathy. Front Biosci (2003) 1.17

High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci (2007) 1.14

15(S)-HETE production in human retinal microvascular endothelial cells by hypoxia: Novel role for MEK1 in 15(S)-HETE induced angiogenesis. Invest Ophthalmol Vis Sci (2007) 1.14

Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Exp Eye Res (2004) 1.14

Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Pathol (2006) 1.10

Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis (2006) 1.10

Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis (2006) 1.09

The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci (2009) 1.07

Hedgehog signaling induces arterial endothelial cell formation by repressing venous cell fate. Dev Biol (2010) 1.07

Specific involvement of SRC family kinase activation in the pathogenesis of retinal neovascularization. Invest Ophthalmol Vis Sci (2006) 1.04

Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis. Invest Ophthalmol Vis Sci (2003) 1.02

The development of the rat model of retinopathy of prematurity. Doc Ophthalmol (2009) 1.01

Role of cytosolic phospholipase A(2) in retinal neovascularization. Invest Ophthalmol Vis Sci (2009) 1.00

Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells. Exp Eye Res (2010) 0.99

Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR. Invest Ophthalmol Vis Sci (2007) 0.95

Improved assessment of laser-induced choroidal neovascularization. Microvasc Res (2010) 0.95

Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF. Exp Eye Res (2010) 0.93

Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2013) 0.91

Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis. Invest Ophthalmol Vis Sci (2009) 0.90

Environmental light and heredity are associated with adaptive changes in retinal DHA levels that affect retinal function. Lipids (2004) 0.89

A novel role for activating transcription factor-2 in 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis. J Lipid Res (2008) 0.88

The effects of nepafenac and amfenac on retinal angiogenesis. Brain Res Bull (2009) 0.88

Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice. Invest Ophthalmol Vis Sci (2011) 0.87

Proteomic analysis of the retina: removal of RPE alters outer segment assembly and retinal protein expression. Glia (2009) 0.82

Mechanisms and management of retinopathy of prematurity. N Engl J Med (2013) 0.81

Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types. Exp Eye Res (2013) 0.80

Retinal angiogenesis suppression through small molecule activation of p53. J Clin Invest (2013) 0.80

Cellular retinol binding protein 1 modulates photoreceptor outer segment folding in the isolated eye. Dev Neurobiol (2010) 0.79

Imaging of endothelial progenitor cell subpopulations in angiogenesis using quantum dot nanocrystals. Methods Mol Biol (2013) 0.76

Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity. Exp Eye Res (2004) 0.76

Circadian perinatal photoperiod has enduring effects on retinal dopamine and visual function. J Neurosci (2014) 0.76

Molecular imaging of retinal disease. J Ocul Pharmacol Ther (2013) 0.76